IHS Chemical Week

World News and Views :: Top of the News

Johnson & Johnson to Buy Remaining Stake in Crucell for €1.75 Billion (update)

5:48 AM MDT | September 17, 2010 | Deepti Ramesh

Biopharmaceutical company Crucell (Leiden, Netherlands) says that it is in advanced negotiations with Johnson & Johnson (J&J; New Brunswick, NJ), for a potential public offer by J&J for all outstanding ordinary shares of Crucell that it does not already own. In September 2009, J&J has purchased about 18% of Crucell’s ordinary shares for a total purchase price of €302 million ($396 million). J&J or an affiliate will acquire all outstanding equity of Crucell that it does not already own for about €1.75 billion, which represents a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa